Index

Show indicators by:

  • Cancer Control Domain
  • Disease Site
  • Dashboard
  • Disease Site
    • Breast
      • Breast cancer screening
      • Screening in underserved populations
      • Breast cancer diagnosis wait time
      • Capture of stage
      • Stage distribution
      • Surgery
        • Breast cancer resections that are mastectomies
        • The use of breast-conserving surgery versus mastectomies for breast cancer resections
      • Radiation therapy
        • Post-operative radiation therapy for stage I or II breast cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Breast cancer screening outside recommended guidelines
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Colorectal
      • Colorectal cancer screening
      • Geographic variation in colorectal cancer risk
      • Screening in underserved populations
      • Colorectal cancer diagnosis wait time
      • Capture of stage
      • Stage distribution
      • Surgery
        • Removal and examination of 12 or more lymph nodes in colon resections
        • Resection rates for stage II or III rectal cancer, stage III colon cancer and stage II or IIIA non-small cell lung cancer patients
      • Radiation therapy
        • Pre-operative radiation therapy for patients with stage II or III rectal cancer
      • Post-operative chemotherapy for stage III colon cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Lung
      • Capture of stage
      • Stage distribution
      • Geographic variation in lung cancer risk
      • Resection rates for stage II or IIIA Non-snmall cell lung cancer patients
      • Post-operative chemotherapy for stage II or IIIA non-small cell lung cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Prostate
      • PSA testing
      • Prostate risk profile
      • Capture of stage
      • Stage distribution
      • Prostate wait times for surgery
      • Prostate wait times for radiation therapy
      • Radical prostatectomy: open versus laparoscopic surgery
      • Prostate patterns of care: radiation and surgical treatment
      • Prostate access to palliative radiation
      • Prostate clinical trials participation
      • Adult clinical trial participation
      • Prostate cancer research investment
      • Cancer research investment
      • Incidence & Mortality Rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Cervical
      • Human papillomavirus (HPV) vaccination
      • Cervical cancer screening
      • Screening in underserved populations
    • Pancreas
      • Incidence and mortality rates
    • Stage Distribution
  • Province & Territory
  • 1. Prevention
  • 2. Screening
  • 3. Diagnosis
  • 4. Treatment
  • 5. Person-Centred Perspective
  • 6. Research
  • 7. Appropriateness
  • 8. Long-term outcomes
  • Smoking prevalence
  • Smoking behaviours in current cancer patients
  • Smoking cessation
  • Second-hand smoke exposure
  • Geographic variation in lung cancer risk
  • Alcohol consumption
  • Adult overweight and obesity
  • Active transportation
  • Physical inactivity
  • Human papillomavirus (HPV) vaccination
  • Fruit and vegetable consumption
  • Geographic variation in colorectal cancer risk
  • Cervical cancer screening
  • Breast cancer screening
  • Colorectal cancer screening
  • PSA testing
  • Screening in underserved populations
  • Breast cancer diagnosis wait times
  • Colorectal cancer diagnosis wait times
  • Capture of stage
  • Stage distribution
  • Prostate risk profile
  • Surgery
  • Radiation therapy
  • Systemic therapy
  • Removal and examination of 12 or more lymph nodes in colon resections
  • Resection rates for stage II or III rectal cancer, stage III colon cancer and stage II or IIIA non-small cell lung cancer patients
  • The use of breast-conserving surgery versus mastectomies for breast cancer resections
  • Breast cancer resections that are mastectomies
  • High-risk, resource-intensive surgeries for esophageal, pancreatic, liver, lung and ovarian cancers in Canada
  • Prostate wait times for surgery
  • Radical prostatectomy: open versus laparoscopic surgery
  • Radiation therapy wait times
  • Radiation therapy utilization and capacity
  • Pre-operative radiation therapy for patients with stage II or III rectal cancer
  • Post-operative radiation therapy for patients with stage I or II breast cancer
  • Prostate wait times for radiation therapy
  • Prostate patterns of care: radiation and surgical treatment
  • Post-operative chemotherapy for stage III colon cancer patients
  • Post-operative chemotherapy for patients with stage II or IIIA non-small cell lung cancer
  • Screening for distress
  • Patient satisfaction
  • Place of death
  • Prostate access to palliative radiation
  • Adult clinical trial participation
  • Prostate clinical trials participation
  • Pediatric clinical trial participation
  • Cancer research investment
  • Prostate cancer research investment
  • Breast cancer screening outside of guidelines
  • Breast cancer mastectomies done as day surgery
  • Intensive care use in the last two weeks of life
  • Breast cancer
  • Lung cancer
  • Colorectal cancer
  • Prostate cancer
  • Pancreatic cancer
  • Five-year net survival by income quintile for several cancers in Canada
System Performance Logo
System Performance
  • About
  • Reports
  • Français
  • Home
  • Cancer control domain
  • 4. Treatment
  • Surgery
  • Resection rates for stage II or III rectal cancer, stage III colon cancer and stage II or IIIA non-small cell lung cancer patients

Resection rates for stage II or III rectal cancer, stage III colon cancer and stage II or IIIA non-small cell lung cancer patients

  • Charts and Tables

    Charts and Tables

    Figure 4.2

    Percentage of Stage II or III rectal cancer patients who had a surgical resection†, by province — from 2009 to 2012 diagnosis years

    • Download & Export

      Figure

      •  

      Data Table

      • CSV
      • Excel
      • Json
      • XML

    “—” Data not available.
    †Data include surgical resections performed within 1 year of diagnosis.
    AB: All coded surgeries were included for complete rectum resection.
    MB: Data limited to complete resections where margins are negative.
    Data source: Provincial cancer agencies and programs.

    Data Table

    Province Diagnosis year Number of rectal resectionsPercent (%)Lower bound of 95% confidence intervalUpper bound of 95% confidence interval
    BC2009----
    BC2010----
    BC2011----
    BC2012----
    AB200928191.287.594.1
    AB201029592.288.794.9
    AB201131992.288.894.8
    AB201233892.689.495.1
    SK20099980.572.487.1
    SK201011395.089.398.1
    SK201111896.791.899.1
    SK2012----
    MB200914583.877.589.0
    MB201012781.474.487.2
    MB201114188.782.793.2
    MB201212986.079.491.1
    ON200994373.571.075.9
    ON2010----
    ON2011----
    ON2012----
    QC2009----
    QC2010----
    QC2011----
    QC2012----
    NB2009-90.9--
    NB20109990.082.894.9
    NB20118998.994.0100.0
    NB201279100.095.4100.0
    NS200912393.988.397.3
    NS201012685.779.090.9
    NS201111485.778.691.2
    NS201212386.079.291.2
    PE20091890.068.398.8
    PE20109100.066.4100.0
    PE20111493.368.199.8
    PE2012----
    NL20097892.985.197.3
    NL20106470.359.879.5
    NL20115764.053.273.9
    NL20127781.171.788.4

    + Expand Table

    “—” Data not available.
    †Data include surgical resections performed within 1 year of diagnosis.
    AB: All coded surgeries were included for complete rectum resection.
    MB: Data limited to complete resections where margins are negative.
    Data source: Provincial cancer agencies and programs.

    Figure 4.3

    Percentage of Stage III colon cancer patients who had a surgical resection†, by province — from 2009 to 2012 diagnosis years

    • Download & Export

      Figure

      •  

      Data Table

      • CSV
      • Excel
      • Json
      • XML

    “—” Data not available.
    †Data include surgical resections performed within 1 year of diagnosis.
    AB: All coded surgeries were included for complete colon resection.
    Data source: Provincial cancer agencies and programs.

    Data Table

    ProvinceDiagnosis yearNumber of colon resectionsPercent (%)Lower bound of 95% confidence intervalUpper bound of 95% confidence interval
    BC2009----
    BC2010----
    BC2011----
    BC2012----
    AB200928498.696.599.6
    AB201029899.397.699.9
    AB201129199.397.699.9
    AB201228797.394.798.8
    SK20098582.573.889.3
    SK201010388.881.693.9
    SK20119281.473.088.1
    SK20129085.777.591.8
    MB200912287.180.492.2
    MB201011284.877.690.5
    MB201114683.977.689.0
    MB201211389.082.293.8
    ON2009----
    ON2010----
    ON2011----
    ON2012----
    QC2009----
    QC2010----
    QC2011----
    QC2012----
    NB2009-96.7--
    NB201090100.096.0100.0
    NB20115681.269.989.6
    NB20127388.079.094.1
    NS2009----
    NS2010----
    NS2011----
    NS2012----
    PE20091593.869.899.8
    PE20101588.263.698.5
    PE201117100.080.5100.0
    PE201223100.085.2100.0
    NL200970100.094.9100.0
    NL20108184.475.591.0
    NL2011----
    NL2012----

    + Expand Table

    “—” Data not available.
    †Data include surgical resections performed within 1 year of diagnosis.
    AB: All coded surgeries were included for complete colon resection.
    Data source: Provincial cancer agencies and programs.

    Figure 4.4

    Percentage of Stage II or IIIA non-small cell lung cancer patients who had a surgical resection†, by province — from 2009 to 2012 diagnosis years

    • Download & Export

      Figure

      •  

      Data Table

      • CSV
      • Excel
      • Json
      • XML

    “—” Data not available.
    †Data include surgical resections performed within 1 year of diagnosis.
    AB: All coded surgeries were included for complete rectum resection.
    MB: Data limited to complete resections where margins are negative.
    Data source: Provincial cancer agencies and programs.

    Data Table

    ProvinceDiagnosis yearNumber of lung resections Percent (%)Lower bound of 95% confidence intervalUpper bound of 95% confidence interval
    PE2009-20101121.611.335.3
    PE2009----
    PE2010----
    PE2011840.019.163.9
    PE2012736.816.361.6
    BC2009----
    BC2010----
    BC2011----
    BC2012----
    AB20095936.028.643.8
    AB20108239.833.146.8
    AB201110734.529.240.1
    AB201214038.133.243.3
    SK20091826.916.839.1
    SK20101925.015.836.3
    SK20113632.423.942.0
    SK20123933.124.742.3
    MB20094847.137.157.2
    MB20105742.233.851.0
    MB20115244.835.654.3
    MB20125241.632.950.8
    ON200933836.233.139.4
    ON2010----
    ON2011----
    ON2012----
    QC2009----
    QC2010----
    QC2011----
    QC2012----
    NB2009----
    NB20104434.626.443.6
    NB20116648.239.656.9
    NB20126741.633.949.6
    NS2009----
    NS20106138.430.846.4
    NS20113630.822.640.0
    NS2012----
    NL2009----
    NL2010----
    NL2011----
    NL2012----

    + Expand Table

    “—” Data not available.
    †Data include surgical resections performed within 1 year of diagnosis.
    AB: All coded surgeries were included for complete rectum resection.
    MB: Data limited to complete resections where margins are negative.
    Data source: Provincial cancer agencies and programs.

  • Data specifications

    Data specifications

    Resection Rate for Patients with Stage II or III Rectal Cancer

    Definition: The percentage of patients diagnosed with stage II or III rectal cancer who had a surgical resection

    Numerator: The number of cases receiving a rectal resection within 1 year of diagnosis

    Denominator: The number of stage II and III rectal cancer cases

    Data source: Provincial cancer agencies

    Measurement timeframe: 2009, 2010, 2011 and 2012 diagnosis years

    Stratification variables: Province, sex, age

    Provinces submitting data: AB, SK, MB, ON, NB, NS, PE, NL

    Province specific notes:

    • AB: For 2009, resections were not necessarily limited to the specified types (complete rectum). For 2010/2011/2012, treatment information is based on initially planned treatment to primary site (ACR data). The CCI codes are not identified in the ACR, as such all coded surgeries were included for complete rectum resection. If more than one surgical procedure is performed, the ACR codes the most definitive procedures is documented. The definition of definitive is the surgical procedure with the intent to cure. There are some procedures could not identify the margins are negative.
    • MB: For 2010/2011/2012, data were not limited to complete resections where margins are negative.
    • NB: For 2010, the surgery information was captured in Cancer Registry instead of Discharge Abstract Database.
    • NS: For 2009, cases from Cumberland Health Authority were included. For 2010, collaborative stage variables were used to identify those having resections. Individual charts were reviewed to obtain resection date. Extension codes were used to identify true resections (i.e. polypectomies were not considered resections. For 2010/2011/2012, data were not limited to complete resections where margin is negative.
    • PE: For 2010/2011, data were not limited to complete resection where margins are negative.
    • NL: For 2010, margin status was not recorded. Ineligible surgeries were excluded. For 2011/2012, data were limited to complete resections where margin is negative.

    Notes:

    1. Rectal cases defined as ICDO3 codes: C19.9 or C20.9, AJCC group stage at diagnosis = II or III.
    2. Excluded lymphoma codes M-95 to M-98. For 2010/2011/2012, data also excluded sarcoma codes (see Appendix 1), neuroendocrine carcinoma, squamous cell carcinoma.
    3. Cases for patients under 18 years of age were excluded.
    4. Rectal resection identified using CCI codes 1NQ87 or 1NQ89 or see list of descriptors in Appendix 1. For 2009/2010, CCI codes also included INQ59.
    5. Resected cases included regardless of margin status.
    6. Included cases which last resection data (if multiple)-diagnosis date<=365 days for 2009. For year 2010, 2011 and 2012, the inclusion definition has been updated to include 1st resection date (if multiple)-diagnosis date<=365.

    Resection Rate for Patients with Stage III Colon Cancer

    Definition: The percentage of patients diagnosed with stage III colon cancer who had a surgical resection

    Numerator: The number of cases receiving a colon resection within 1 year of diagnosis

    Denominator: The number of stage III colon cancer cases

    Data source: Provincial cancer agencies

    Measurement timeframe: 2009, 2010, 2011 and 2012 diagnosis year

    Stratification variables: Province, sex, age

    Provinces submitting data: AB, SK, MB, NB, PE, NL

    Province specific notes:

    • AB: For 2009, data did not limited to complete resections (colectomy). For 2010/2011/2012, treatment information is based on initially planned treatment to primary site (ACR data). The CCI codes are not identified in the ACR, as such all coded surgeries were included for complete rectum resection. If more than one surgical procedure is performed, the ACR codes the most definitive procedures is documented. The definition of definitive is the surgical procedure with the intent to cure. There are some procedures could not identify the margins are negative. For 2011/2012, through quality assurance, there are a number of cases coded as surgery on the ACR had CCI codes or Billing codes other than the ones listed. The majority of these cases appear to be cases in which the DAD had resection of the rectum even though the patient only had C18.7 sigmoid colon. There are also some cases in which the ACR codes surgery for colon but no records were found in the Inpatient database or Billing data. This may be out of province resection.
    • SK: For 2012, data were not limited to complete resections where margins are negative.
    • MB: For 2010/2011/2012, data were not limited to complete resections where margins are negative.
    • NB: For 2010, the surgery information was captured in Cancer Registry instead of Discharge Abstract Database. For 2012, all surgeries were included where margins are positive or negative.
    • PE: For 2010/2011, data were not limited to complete resection where margins are negative.
    • NL: For 2010, margin status was not recorded. Ineligible surgeries were excluded. For 2011/2012, data were limited to complete resections where margin is negative.

    Notes:

    1. Colon cases defined as ICDO3 codes: C18.0-C18.9 for 2009, C18.0 and C18.2 to C18.9 for 2010/ 2011/2012, AJCC group stage at diagnosis = III.
    2. Excluded lymphoma codes M-95 to M-98. For 2010/2011/2012, data also excluded sarcoma codes (see Appendix 1), neuroendocrine carcinoma, squamous cell carcinoma.
    3. Cases for patients under 18 years of age were excluded.
    4. Colon resection identified using CCI codes 1NM87 or 1NM89 or 1NM91 or list of descriptors in Appendix 1.
    5. Resected cases included regardless of margin status.
    6. Included cases which last resection data (if multiple)-diagnosis date<=365 days for 2009. For year 2010, 2011 and 2012, the inclusion definition has been updated to include 1st resection date (if multiple)-diagnosis date<=365.

    Resection Rate for Patients with Stage II or IIIA Non-Small Cell Lung Cancer

    Definition: The percentage of patients diagnosed with stage II or IIIA non-small cell lung cancer who had a surgical resection

    Numerator: The number of cases receiving a surgical resection within 1 year of diagnosis

    Denominator: The number of stage II or IIIA non-small cell lung cancer cases

    Data source: Provincial cancer agencies

    Measurement timeframe: 2009, 2010, 2011 and 2012 diagnosis year

    Stratification variables: Province, sex, age

    Provinces submitting data: AB, SK, MB, ON, NB, NS, PE

    Province specific notes:

    • AB: For 2009, resections not necessarily limited to the specified types (lobectomy, pneumonectomy or segmentectomy). For 2010/2011/2012, treatment information is based on initially planned treatment to the primary site (ACR data). The CCI codes are not identified in the ACR, as such all coded surgeries were included for complete lung resection. If more than one surgical procedure is performed, the most definitive procedure is documented. The definition of definitive is the surgical procedure with the intent to care. This indicator excludes case with stage=”III”.
    • SK, MB: For 2012, all surgeries are included where margins are unable to identify as negative.
    • NS: For 2010/2011, collaborative stage variables were used to identify those having resections. Individual chart were reviewed to obtain resection date.

    Notes:

    1. Non-small cell lung cases defined as ICDO3 codes: C34.0 to C34.9, AJCC group stage at diagnosis = II or IIIA.
    2. Excluded lymphoma codes M-95 to M-98. For 2010/2011/2012, data also excluded sarcoma codes (see Appendix 1), neuroendocrine carcinoma. For 2010/2011, squamous cell carcinomas was also excluded, but included in 2012.
    3. Excluded histology codes: 8002, 8041, 8043, 8044, 8045, 8073 and 8803 in 2010/2011/2012 data.
    4. Cases for patients under 18 years of age were excluded.
    5. Lung resections defined as CCI codes 1GR87, 1GR89, 1GR91, 1GT59, 1GT87, 1GT89 or 1GT91 or list of descriptors in Appendix 1.
    6. Resected cases included regardless of margin status (due to data limitations).
    7. Included cases which last resection data (if multiple)-diagnosis date<=365 days.
  • Related indicators

    Related Indicators

    Post-operative chemotherapy for stage III colon cancer patients

    Percentage of Stage III colon cancer patients receiving chemotherapy following surgical resection, by age group — from 2009 to 2012 diagnosis years
    View this indicator
    Post-operative chemotherapy for patients with stage II or IIIA non-small cell lung cancer

    Percentage of patients with Stage II or IIIA non-small cell lung cancer who received chemotherapy following surgical resection, by age group, jurisdictions combined† — 2011 to 2014  diagnosis years
    View this indicator
  • About Us
  • Careers
  • Contact
  • Media centre
  • Share your feedback
  • About our new site

  • Français Language toggle.

Other related sites:

  • Canadian Partnership for Tomorrow’s Health
  • Canadian Cancer Research Alliance
  • Canadian Cancer Trials
  • facebook
  • twitter
  • youtube
  • linkedin
    CPAC Logo

    Questions about cancer?

    For information about cancer treatment and support for patients, please contact the Canadian Cancer Society at 1-888-939-3333 or by completing this online form.

  • AODA compliance
  • Privacy policy
  • Terms of use
  • FAQ
  • Site map
  • About this site
© Canadian Partnership Against Cancer Corporation